22 minutes ago
If approved, the novel corticosteroid therapy would be the first and only FDA-approved hydrocortisone acetate suppository.
1 hour ago
The FDA accepted Genentech's sBLA for obinutuzumab in SLE based on positive phase 3 ALLEGORY trial results, with a decision expected by December 2026.
1 hour ago
54-week STOP-HS data show clinically meaningful improvements in pain, fatigue, and quality of life in one-third to two-thirds of patients.
16 hours ago
Following an April 18 executive order, Gus Alva, MD, discusses psychedelic mechanisms, evidence, and clinical considerations for psychiatry.
17 hours ago